UNVEILING THE EXPANDING CLINICAL HORIZONS OF BOTULINUM TOXIN ACROSS MEDICAL SPECIALITIES
Abstract
Introduction: Originally identified for its potent neurotoxicity, botulinum toxin (BoNT) has been successfully repurposed into a highly versatile agent used across numerous medical specialities. Through targeted inhibition of acetylcholine release at neuromuscular synapses, BoNT induces localized, reversible muscle relaxation, effectively alleviating symptoms in a variety of neuromuscular and autonomic disorders.
Aim: This review aims to highlight the approved therapeutic uses of BoNT, its expanding applications, and the importance of proper technique and anatomical knowledge in maximizing efficacy and minimizing adverse events.
Materials and Methods: A comprehensive literature review was conducted to evaluate current therapeutic indications, mechanisms of action, safety profile, and emerging uses of BoNT.
Results: Approved therapeutic indications include dystonias, spasticity, chronic migraine, hyperhidrosis, bruxism, while growing evidence supports its emerging role in pain management, selected psychiatric disorders and certain cardiovascular conditions. In aesthetic medicine, BoNT remains primary non-surgical option for addressing dynamic facial lines and hyperfunctional musculature. The safty profile of BoNT remains favorable, however, the efficacy and safety of BoNT is strongly linked to appropriate dosing, product selection, formulation and precise injection technique, emphasizing the critical role of anatomical knowledge to maximize therapeutic benefit while minimizing adverse events.
Conclusion: Botulinum toxin has evolved from a potent neurotoxin to a valuable therapeutic agent across a broad range of medical disciplines. Its continued success depends on deep understanding of anatomy, product characteristics, and injection technique. Ongoing research into novel serotypes, delivery systems, and expanded indications will further solidify BoNT’s role as a cornerstone in both therapeutic and aesthetic practice.
References
Whitcup, S. M. (2021). The history of botulinum toxins in medicine: A thousand year journey. Handbook of Experimental Pharmacology, 263, 3–10. doi: 10.1007/164_2019_271.
Choudhury, S., Baker, M. R., Chatterjee, S., & Kumar, H. (2021). Botulinum toxin: An update on pharmacology and newer products in development. Toxins, 13(1), 58. doi:10.3390/toxins13010058
Pellett, S., Bradshaw, M., Tepp, W. H., Pier, C. L., Whitemarsh, R. C. M., Chen, C., Barbieri, J. T., & Johnson, E. A. (2018). The light chain defines the duration of action of botulinum toxin serotype A subtypes. mBio, 9(2), e00089-18. doi: 10.1128/mBio.00089-18
Ledda, C., Artusi, C. A., Tribolo, A., Rinaldi, D., Imbalzano, G., Lopiano, L., & Zibetti, M. (2022). Time to onset and duration of botulinum toxin efficacy in movement disorders. Journal of Neurology, 269(7), 3706–3712. doi: 10.1007/s00415-022-10995-2
Nigam, P. K., & Nigam, A. (2010). Botulinum toxin. Indian Journal of Dermatology, 55(1), 8–14. doi: 10.4103/0019-5154.60343
Wee, S. Y., & Park, E. S. (2022). Immunogenicity of botulinum toxin. Archives of Plastic Surgery, 49(1), 12–18. doi:10.5999/aps.2021.00766
Leszczynska, A., Nowicka, D., Pillunat, L. E., & Szepietowski, J. C. (2024). Five decades of the use of botulinum toxin in ophthalmology. Indian Journal of Ophthalmology, 72, 789–795. doi: 10.4103/IJO.IJO_1030_23
Sabetti, L., Guetti, F., Pomanti, V., & Murano, G. (2022). Botulinum toxin for the treatment of nystagmus associated with exotropia. Open Journal of Ophthalmology, 12, Article 4. doi: 10.4236/ojoph.2022.124036
Alsuhaibani, A. H., & Eid, S. A. (2018). Botulinum toxin injection and tear production. Current Opinion in Ophthalmology, 29, 428–433. doi: 1097/ICU.0000000000000506
Yücel, O. E., & Artürk, N. (2012). Botulinum toxin-A-induced protective ptosis in the treatment of lagophthalmos associated with facial paralysis. Ophthalmic Plastic and Reconstructive Surgery, 28, 256–260. doi: 10.1097/IOP.0b013e31824ee702
Deka, A., & Saikia, S. P. (2010). Lower lid entropion correction with botulinum toxin injection. Oman Journal of Ophthalmology, 3, 158–159. doi: 10.4103/0974-620X.71909
Sławek, J., & Wolfgang, H. (2021). Botulinum neurotoxin in neurological practice. Polish Journal of Neurology and Neurosurgery, 55(2), 120–124. doi: 10.5603/PJNNS.a2021.0034
Chiu, S. Y., Burns, M. R., & Malaty, I. A. (2021). An update on botulinum toxin in neurology. Neurologic Clinics, 39(2), 209–229. doi: 10.1016/j.ncl.2020.09.014
Becker, W. J. (2020). Botulinum toxin in the treatment of headache. Toxins, 12(12), 803. doi: 10.3390/toxins12120803
Schinwelski, M., & Sławek, J. (2013). Toksyna botulinowa w neurologii [Botulinum toxin in neurology]. Neurologia po Dyplomie, 8(3), 7–18.
Różniecki, J. J., Stępień, A., & Domitrz, I. (2018). Leczenie migreny przewlekłej — zalecenia opracowane przez Grupę Ekspertów Polskiego Towarzystwa Bólów Głowy i Sekcji Badania Bólu Polskiego Towarzystwa Neurologicznego [Chronic migraine treatment — recommendations developed by the Expert Group of the Polish Headache Society and the Pain Study Section of the Polish Neurological Society]. Varia Medica, 2(5), 402–408.
Orasanu, B., & Mahajan, S. T. (2013). The use of botulinum toxin for the treatment of overactive bladder syndrome. Indian Journal of Urology, 29(1), 2–11. doi: 10.4103/0970-1591.109975
Licow, A., Ciecwiez, S., & Brodowska, A. (2023). Quality of life in patients with overactive bladder following botulinum toxin treatment: A preliminary report. Ginekologia Polska, 94(8), 593–598. doi: 10.5603/GP.a2022.0105
Kumar, R. (2018). Therapeutic use of botulinum toxin in pain treatment. Neuronal Signaling, 2(3), NS20180058. doi: 10.1042/NS20180058
Park, J., & Park, H. J. (2017). Botulinum toxin for the treatment of neuropathic pain. Toxins, 9(9), 260. doi: 10.3390/toxins9090260
Sim, W. S. (2011). Application of botulinum toxin in pain management. Korean Journal of Pain, 24(1), 1–6. doi: 10.3344/kjp.2011.24.1.1
Naumann, M., So, Y., Argoff, C. E., et al. (2008). Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review). Neurology, 70(19), 1707–1714. doi: 10.1212/01.wnl.0000311390.87642.d8
Fatani, B. (2023). An approach for gummy smile treatment using botulinum toxin A: A narrative review of the literature. Cureus, 15(1), e34032. doi: 10.7759/cureus.34032
Rasteau, S., Savoldelli, C., Winter, C., Lerhe, B., Castillo, L., & Kestemont, P. (2022). Botulinum toxin type A for the treatment of excessive gingival display – A systematic review. Journal of Stomatology, Oral and Maxillofacial Surgery, 123(6), e717–e723. doi: 10.1016/j.jormas.2022.05.016
Long, H., Liao, Z., Wang, Y., Liao, L., & Lai, W. (2012). Efficacy of botulinum toxins on bruxism: An evidence-based review. International Dental Journal, 62(1), 1–5. doi: 10.1111/j.1875-595X.2011.00085.x
Lee, S. J., McCall, W. D. Jr., Kim, Y. K., Chung, S. C., & Chung, J. W. (2010). Effect of botulinum toxin injection on nocturnal bruxism: A randomized controlled trial. American Journal of Physical Medicine & Rehabilitation, 89(1), 16–23. doi: 10.1097/PHM.0b013e3181bc0c78
Buzatu, R., Luca, M. M., Castiglione, L., & Sinescu, C. (2024). Efficacy and safety of botulinum toxin in the management of temporomandibular symptoms associated with sleep bruxism: A systematic review. Dentistry Journal (Basel), 12(6), 156. doi: 10.3390/dj12060156
Fernández-Núñez, T., Amghar-Maach, S., & Gay-Escoda, C. (2019). Efficacy of botulinum toxin in the treatment of bruxism: Systematic review. Medicina Oral, Patología Oral y Cirugía Bucal, 24(4), e416–e424. doi: 10.4317/medoral.22923
Cheng, J., ElMinshawi, A., Courtney, R., & Barry, T. (2023). A retrospective study on the use of botulinum toxin as part of first line of management in the treatment of myogenous temporomandibular disorders (TMD). Journal of the International Dental Association (JIDA). Advance online publication. doi: 10.58541/001c.82024
Saini, R. S., Ali Abdullah Almoyad, M., Binduhayyim, R. I. H., et al. (2024). The effectiveness of botulinum toxin for temporomandibular disorders: A systematic review and meta-analysis. PLoS One, 19(3), e0300157. doi: 10.1371/journal.pone.0300157
Delcanho, R., Val, M., Guarda Nardini, L., & Manfredini, D. (2022). Botulinum toxin for treating temporomandibular disorders: What is the evidence? Journal of Oral & Facial Pain and Headache, 36(1), 6–20. doi: 10.11607/ofph.3023
Lowe, N., Naumann, M., & Eadie, N. (2023). Treatment of hyperhidrosis with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine (Baltimore), 102(S1), e32764. doi: 10.1097/MD.0000000000032764
Harker, M. (2013). Psychological sweating: A systematic review focused on aetiology and cutaneous response. Skin Pharmacology and Physiology, 26(2), 92–100. doi: 10.1159/000346930
Schote, A. B., Dietrich, K., Linden, A. E., et al. (2022). Real sweating in a virtual stress environment: Investigation of the stress reactivity in people with primary focal hyperhidrosis. PLoS One, 17(8), e0272247. doi: 10.1371/journal.pone.0272247
Walling, H. W. (2011). Clinical differentiation of primary from secondary hyperhidrosis. Journal of the American Academy of Dermatology, 64(4), 690–695. doi: 10.1016/j.jaad.2010.03.013
Lowe, N. J., Glaser, D. A., Eadie, N., et al. (2007). Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: A 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety. Journal of the American Academy of Dermatology, 56(4), 604–611. doi: 10.1016/j.jaad.2007.01.009
Moga, M. A., Dimienescu, O. G., Bălan, A., Scârneciu, I., Barabaș, B., & Pleș, L. (2018). Therapeutic approaches of botulinum toxin in gynecology. Toxins, 10(4), 169. doi: 10.3390/toxins10040169
Etrusco, A., Geru, M., Laganà, A. S., Chiantera, V., Giannini, A., & Buzzaccarini, G. (2023). Use of botulinum toxin in aesthetic medicine and gynaecology: Current approaches, controversies, and future directions. Przegląd Menopauzalny (Menopause Review), 22(3), 155–160. doi: 10.5114/pm.2023.131457
Carruthers, A., & Carruthers, J. (1998). History of the cosmetic use of Botulinum A exotoxin. Dermatologic Surgery, 24(11), 1168–1170. doi: 10.1111/j.1524-4725.1998.tb04092.x
Dorizas, A., Krueger, N., & Sadick, N. S. (2014). Aesthetic uses of the botulinum toxin. Dermatologic Clinics, 32(1), 23–36. doi: 10.1016/j.det.2013.09.009
Hong, S. O. (2023). Cosmetic treatment using botulinum toxin in the oral and maxillofacial area: A narrative review of esthetic techniques. Toxins (Basel), 15(2), 82. doi: 10.3390/toxins15020082
Sugrue, C. M., Kelly, J. L., & McInerney, N. (2019). Botulinum toxin treatment for mild to moderate platysma bands: A systematic review of efficacy, safety, and injection technique. Aesthetic Surgery Journal, 39(2), 201–206. doi: 10.1093/asj/sjy179
Erbguth, F. J. (2008). From poison to remedy: The chequered history of botulinum toxin. Journal of Neural Transmission (Vienna), 115(4), 559–565. doi: 10.1007/s00702-007-0728-2
Rossetto, O., Pirazzini, M., & Montecucco, C. (2014). Botulinum neurotoxins: Genetic, structural and mechanistic insights. Nature Reviews Microbiology, 12(8), 535–549. doi: 10.1038/nrmicro3295
Naumann, M., & Jankovic, J. (2004). Safety of botulinum toxin type A: A systematic review and meta-analysis. Current Medical Research and Opinion, 20(7), 981–990. doi: 10.1185/030079904125003962
Dressler, D., Saberi, F. A., Kollewe, K., & Schrader, C. (2015). Safety aspects of incobotulinumtoxinA high-dose therapy. Journal of Neural Transmission (Vienna), 122(2), 327–333. doi: 10.1007/s00702-014-1252-9
Dressler, D., & Johnson, E. A. (2022). Botulinum toxin therapy: Past, present and future developments. Journal of Neural Transmission, 129, 829–833. doi: 1007/s00702-022-02494-5
Demchenko, I., Swiderski, A., Liu, H., Jung, H., Lou, W., & Bhat, V. (2024). Botulinum toxin injections for psychiatric disorders: A systematic review of the clinical trial landscape. Toxins, 16(4), 191. doi: 10.3390/toxins16040191
Pokushalov, E., Romanov, A., Corbucci, G., et al. (2014). A randomized comparison of botulinum toxin injection versus standard therapy for preventing atrial fibrillation after coronary artery bypass surgery. Journal of the American College of Cardiology, 63(2), 110–116. doi: 10.1016/j.jacc.2013.09.02
Views:
13
Downloads:
11
Copyright (c) 2025 Katarzyna Herjan, Piotr Armański, Gabriela Łocik, Marta Bonarska, Joanna Wróbel, Katarzyna Kozon
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
